Suitas, Klia .

HRN: 14-81-93  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/07/2024
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
09/07/2024
09/13/2024
PO
7ml
TID
Amoebiasis
Waiting Final Action 
09/08/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/08/2024
09/14/2024
IV
180mg
Q8h
Amoebiasis
Waiting Final Action 
09/09/2024
CEFTRIAXONE 1G (VIAL)
09/09/2024
09/16/2024
9
1.5g
OD
AGE With Mod Dehydration, Amoebiasis
Waiting Final Action 
09/12/2024
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
09/12/2024
09/19/2024
IV
7ml
TID
Amoebiasis
Waiting Final Action 
09/13/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/13/2024
09/20/2024
IV
1.8grams
Q8
Amoebiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: